Improving Treatment of Newly Diagnosed Osteoporosis

此应用程序的目的是支持和促进博士的职业发展。 成为一名杰出的临床科学家和独立研究人员。对于这个应用程序，克拉姆博士 组建了一个由经验丰富的导师组成的团队（Janet Schlechte博士（初级导师），Alan Christensen博士（联合导师）， 导师）和罗伯特华莱士（共同导师）），以确保他的成功发展。克拉姆博士的研究 关注骨质疏松症患者的治疗障碍。为了实现他的目标，克拉姆博士 将沉浸在严格的研究，通过集中教程和阅读指导他的导师。他将 还完成生物统计学和调查研究，健康心理学等领域的目标课程， 研究的道德行为。此外，在Schlechte博士的指导下，他将获得 骨质疏松症患者的临床管理。在资助期间，候选人将进行 在三个不同的研究地点进行三个连续和渐进的项目， 在筛选双能X线骨密度测定法确定为骨质疏松症的患者中 (DXA)扫描.项目1将涉及详细的医疗记录审查，以确定患者和医生的具体 DXA筛查后诊断为骨质疏松症患者治疗不足的相关因素。 项目2（从第18个月开始）将检查患者是否愿意接受DXA扫描 结果然后，研究人员将检查患者对通知他们的偏好之间的关系。 结果以及社会人口和心理特征。项目3（从第48个月开始）将以 根据项目1和2的结果。这项随机试验将评估患者激活 干预，包括将DXA扫描结果与教育材料一起沿着给患者 对其结果进行解释，可以提高骨质疏松症的治疗效果和患者的满意度。 最后，这项工作将作为一个模型，检查的障碍，并改善治疗其他慢性 通过筛查发现的疾病。

The objective of this application is to support and foster the career development of Dr. Peter Cram in becoming an outstanding clinician-scientist and independent researcher. For this application, Dr. Cram has assembled a team of experienced mentors (Drs. Janet Schlechte (Primary Mentor), Alan Christensen (Co- Mentor), and Robert Wallace (Co-Mentor)) to insure his successful development. Dr. Cram's research will focus on the barriers to treatment of patients with osteoporosis. In order to accomplish his goals, Dr. Cram will immerse himself in rigorous study through focused tutorials and readings guided by his mentors. He will also complete targeted coursework in areas of biostatistics and survey research, health psychology, and ethical conduct of research. In addition, under the guidance of Dr. Schlechte, he will gain expertise in the clinical management of patients with osteoporosis. During the funding period, the candidate will conduct three sequential and incremental projects at three different study sites that examine barriers to treatment among patients who are identified as having osteoporosis on screening dual energy x-ray absorptiometry (DXA) scan. Project 1 will involve a detailed medical record review to identify patient and physician-specific factors associatedwith undertreatment of patients diagnosed with osteoporosis after screening DXA scans. Project 2 (beginning in month 18) will examine patient preferences for being notified of their DXA scan results. The investigators will then examine relationships between patient preferences for notification of their results and socio-demographic and psychological traits. Project 3 (beginning in month 48) will be based upon the results of Projects 1and 2. This randomized trial will assess whether a patient activation intervention, consisting of mailing patients the results of their DXA scans along with educational material about the interpretation of their results, can improve the treatment of osteoporosis and patient satisfaction. Finally, this work will serve as a model for examining the barriers to and improving treatment of other chronic diseases identified through screening.